Victor Grifols Roura leave company chairmanship. Pharmaceutical company Grifols appointed Steven F Mayer as the new CEO. The appointment mandated changes to the bylaws of the board, which would now “allow the position of chairman to be assumed by an executive director, in which case his appointment would require an affirmative vote of two-thirds of the members of the board,” according to a communication to the CNMV. Víctor Grífols Roura, who has devoted more than 50 years to shaping the current Grifols with over 30 different positions of responsibility, including CEO, was named honorary chairman for his contributions, although he will remain a member of the Board of Directors. Grifols Managers as registered director.
Steven F MayerFormer co-director of Cerberus Global Private Equity and chairman of the investment committee of Cerberus Capital Management, he has been an independent director of Grifols for over 10 years. “These changes once again demonstrate the total commitment of the board to strategic goals, operational excellence and leverage reduction,” the company said in a statement. Reducing debt at increasing rates requires a financial expert at the head of the company.
After 21 years in office, Victor Grifols Roura He leaves his Catalan lab at a needy stage and is forced to dispel any doubts about his future, both inside and outside the company. In any case, Grifols is the world leader in plasma derivatives with a presence on all continents and, according to most analysts, one of the least valued companies in ‘hardwood’. However, it is a sensitive moment for the stock market and it is necessary to feed the market with good news that dampens overall trends. To this end, although Grifols’ involvement will continue as it has been until now, Steven F. Mayer assumes the position in this vital transition from being a family business to the professionalization of maximum responsibility.
The new president’s financial profile raises some internal fears over the possibility of seeking stock market revaluation through traditional staff adjustments. The company has lost more than 45% in the stock market and this revaluation is taking longer than expected, although analysts have always given it confidence and a potential upside. The new president will work hand in hand with the CEOs, Victor Grifols Deu Y Raimon Grifols Roura’s photo.however, their choice allows any decision to be made while minimizing the erosion of the family’s role in the company.